Apogee’s zumilokibart meets Phase 2 trial endpoints in dermatitis

Markets Investing.com By Investing.com 27 May 2026 10:37 1 min read

Apogee’s zumilokibart meets Phase 2 trial endpoints in dermatitis

Apogee’s zumilokibart meets Phase 2 trial endpoints in dermatitis

Apogee’s zumilokibart meets Phase 2 trial endpoints in dermatitis

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.